These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34874508)

  • 1. Systematic Evaluation of the Effect of Formulation Variables on In Vitro Performance of Mometasone Furoate Suspension-Metered Dose Inhalers.
    Bachhav SS; Sheth P; Sandell D; Svensson M; Bhagwat S; Conti DS; Oguntimein O; Dhapare S; Saluja B; Winner L; Bulitta JB; Hochhaus G
    AAPS J; 2021 Dec; 24(1):9. PubMed ID: 34874508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
    Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
    AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
    Amar NJ; Shekar T; Varnell TA; Mehta A; Philip G
    Pediatr Pulmonol; 2017 Mar; 52(3):310-318. PubMed ID: 27740721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valved Holding Chambers and In Vitro Metered Dose Inhaler Performance: Effects of Flow Rate and Inhalation Delay.
    Liu X; Guo C; Chowdhury B; Starke P; Limb S; Peri P; Schroeder A; Doub W
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):399-410. PubMed ID: 28846482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
    Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Bio-relevant Mouth-Throat Models for Characterization of Metered Dose Inhalers.
    Kaviratna A; Tian G; Liu X; Delvadia R; Lee S; Guo C
    AAPS PharmSciTech; 2019 Feb; 20(3):130. PubMed ID: 30815748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary peptide delivery: effect of taste-masking excipients on leuprolide suspension metered-dose inhalers.
    Zheng JY; Fulu MY; Lee DY; Barber TE; Adjei AL
    Pharm Dev Technol; 2001 Nov; 6(4):521-30. PubMed ID: 11775953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler.
    Pickering H; Pitcairn GR; Hirst PH; Bacon PR; Newman SP; Affrime MB; Marino M
    Clin Ther; 2000 Dec; 22(12):1483-93. PubMed ID: 11192139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an abbreviated impactor for fine particle fraction (FPF) determination of metered dose inhalers (MDI).
    Guo C; Ngo D; Ahadi S; Doub WH
    AAPS PharmSciTech; 2013 Sep; 14(3):1004-11. PubMed ID: 23780781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device.
    Kosoglou T; Hubbell J; Johnson-Levonas AO; Yunan M; Kantesaria BS; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):222-8. PubMed ID: 27128612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Geometric and Aerodynamic Particle Size Distributions in the Formulation of Solution and Suspension Metered-Dose Inhalers.
    Yoshida H; Usui A; Abe Y; Goda Y; Izutsu KI
    AAPS PharmSciTech; 2020 May; 21(5):158. PubMed ID: 32458106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
    Sheth P; Grimes MR; Stein SW; Myrdal PB
    Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
    Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO
    Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.